These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30813920)

  • 1. Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report.
    Fu L; Liu Y; Chen Y; Yuan Y; Wei W
    BMC Pediatr; 2019 Feb; 19(1):68. PubMed ID: 30813920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in PIGL in a patient with Mabry syndrome.
    Fujiwara I; Murakami Y; Niihori T; Kanno J; Hakoda A; Sakamoto O; Okamoto N; Funayama R; Nagashima T; Nakayama K; Kinoshita T; Kure S; Matsubara Y; Aoki Y
    Am J Med Genet A; 2015 Apr; 167A(4):777-85. PubMed ID: 25706356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels.
    Nakamura K; Osaka H; Murakami Y; Anzai R; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Kinoshita T; Matsumoto N; Saitsu H
    Epilepsia; 2014 Feb; 55(2):e13-7. PubMed ID: 24417746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic analysis of two Chinese infants with Mabry syndrome.
    Xue J; Li H; Zhang Y; Yang Z
    Brain Dev; 2016 Oct; 38(9):807-18. PubMed ID: 27177984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome.
    Chiyonobu T; Inoue N; Morimoto M; Kinoshita T; Murakami Y
    J Med Genet; 2014 Mar; 51(3):203-7. PubMed ID: 24367057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
    Krawitz PM; Murakami Y; Rieß A; Hietala M; Krüger U; Zhu N; Kinoshita T; Mundlos S; Hecht J; Robinson PN; Horn D
    Am J Hum Genet; 2013 Apr; 92(4):584-9. PubMed ID: 23561847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder.
    Thompson MD; Knaus AA; Barshop BA; Caliebe A; Muhle H; Nguyen TTM; Baratang NV; Kinoshita T; Percy ME; Campeau PM; Murakami Y; Cole DE; Krawitz PM; Mabry CC
    Eur J Med Genet; 2020 Apr; 63(4):103822. PubMed ID: 31805394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.
    Horn D; Wieczorek D; Metcalfe K; Barić I; Paležac L; Cuk M; Petković Ramadža D; Krüger U; Demuth S; Heinritz W; Linden T; Koenig J; Robinson PN; Krawitz P
    Eur J Hum Genet; 2014 Jun; 22(6):762-7. PubMed ID: 24129430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, genetic, and molecular characterization of hyperphosphatasia with mental retardation: a case report and literature review.
    Abi Farraj L; Khatoun WD; Abou Chebel N; Wakim V; Dawali K; Ghassibe-Sabbagh M
    Diagn Pathol; 2019 Nov; 14(1):123. PubMed ID: 31684969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGAP3-related hyperphosphatasia with mental retardation syndrome: Report of 10 new patients and a homozygous founder mutation.
    Abdel-Hamid MS; Issa MY; Otaify GA; Abdel-Ghafar SF; Elbendary HM; Zaki MS
    Clin Genet; 2018 Jan; 93(1):84-91. PubMed ID: 28390064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineating the phenotypic spectrum of hyperphosphatasia with mental retardation syndrome 4 in 14 patients of Middle-Eastern origin.
    Balobaid A; Ben-Omran T; Ramzan K; Altassan R; Almureikhi M; Musa S; Al-Hashmi N; Al-Owain M; Al-Zaidan H; Al-Hassnan Z; Imtiaz F; Al-Sayed M
    Am J Med Genet A; 2018 Dec; 176(12):2850-2857. PubMed ID: 30345601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphosphatasia with mental retardation syndrome type 4 In two siblings-expanding the phenotypic and mutational spectrum.
    Akgün Doğan Ö; Demir GÜ; Kosukcu C; Taskiran EZ; Simsek-Kiper PÖ; Utine GE; Alikaşifoğlu M; Boduroğlu K
    Eur J Med Genet; 2019 Jun; 62(6):103535. PubMed ID: 30217754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIGW-related glycosylphosphatidylinositol deficiency: A case report and literature review.
    Fang Z; Hu C; Zhou S; Yu L
    Neurol Sci; 2024 May; 45(5):2253-2260. PubMed ID: 38055078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphatasia with mental retardation syndrome type 4 in three unrelated South African patients.
    Bezuidenhout H; Bayley S; Smit L; Kinnear C; Möller M; Uren C; Urban MF
    Am J Med Genet A; 2020 Oct; 182(10):2230-2235. PubMed ID: 32845056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Flow Cytometry for Diagnosis of Epilepsy Associated With Homozygous PIGW Variants.
    Foskett GK; Engleman E; Klotz J; Choi O; Tolentino L; Kochhar A; Yang QZ; Stevenson DA
    Pediatr Neurol; 2018 Aug; 85():67-70. PubMed ID: 30078644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIGW-related glycosylphosphatidylinositol deficiency: Description of a new patient and review of the literature.
    Peron A; Iascone M; Salvatici E; Cavirani B; Marchetti D; Corno S; Vignoli A
    Am J Med Genet A; 2020 Jun; 182(6):1477-1482. PubMed ID: 32198969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the phenotypic spectrum of Mabry Syndrome with novel PIGO gene variants associated with hyperphosphatasia, intractable epilepsy, and complex gastrointestinal and urogenital malformations.
    Holtz AM; Harrington AW; McNamara ER; Kielian A; Soul JS; Martinez-Ojeda M; Levy PT
    Eur J Med Genet; 2020 Apr; 63(4):103802. PubMed ID: 31698102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome.
    Knaus A; Awaya T; Helbig I; Afawi Z; Pendziwiat M; Abu-Rachma J; Thompson MD; Cole DE; Skinner S; Annese F; Canham N; Schweiger MR; Robinson PN; Mundlos S; Kinoshita T; Munnich A; Murakami Y; Horn D; Krawitz PM
    Hum Mutat; 2016 Aug; 37(8):737-44. PubMed ID: 27120253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
    Krawitz PM; Murakami Y; Hecht J; Krüger U; Holder SE; Mortier GR; Delle Chiaie B; De Baere E; Thompson MD; Roscioli T; Kielbasa S; Kinoshita T; Mundlos S; Robinson PN; Horn D
    Am J Hum Genet; 2012 Jul; 91(1):146-51. PubMed ID: 22683086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excluding Digenic Inheritance of
    Thompson MD; Li X; Spencer-Manzon M; Andrade DM; Murakami Y; Kinoshita T; Carpenter TO
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.